TalkMed CEO suspended for eight months
PROMINENT cancer specialist Ang Peng Tiam, who is the chief executive officer and main revenue contributor of Catalist-listed TalkMed Group, has been given an eight-month suspension by the Singapore Medical Council after a failed appeal against a misconduct conviction.
Dr Ang contributes over half of the revenue of the firm. He had originally appealed against his S$25,000 fine by the Singapore Medical Council.
TalkMed requested for a trading halt on Wednesday morning. Its shares last traded at S$0.745.
Share with us your feedback on BT's products and services
TRENDING NOW
32 companies, 6 individuals bag accolades at Singapore Corporate Awards 2026
He built the Vingroup empire. Now South-east Asia’s richest man is handing some key roles to his sons
URA to review guidelines on floor space to give developers more design flexibility: Chee Hong Tat
Chagee, Mixue and Luckin won the market. Sustaining their edge is the harder part